ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
Myalgia | 15.05.02.001 | 0.000533% | | |
Mycosis fungoides | 23.07.04.008; 16.17.03.001; 01.11.03.001 | 0.000799% | | Not Available |
Nausea | 07.01.07.001 | - | - | |
Neoplasm malignant | 16.16.01.001 | - | - | Not Available |
Neutropenia | 01.02.03.004 | 0.000799% | | Not Available |
Neutrophil count decreased | 13.01.06.010 | 0.001066% | | |
Night sweats | 23.02.03.006; 08.01.03.031 | - | - | Not Available |
Oedema | 14.05.06.010; 08.01.07.006 | - | - | Not Available |
Pain in extremity | 15.03.04.010 | - | - | |
Pancytopenia | 01.03.03.003 | 0.001865% | | Not Available |
Platelet count decreased | 13.01.04.001 | 0.002664% | | |
Pneumonia | 22.07.01.003; 11.01.09.003 | 0.000799% | | Not Available |
Pruritus | 23.03.12.001 | - | - | |
Pyrexia | 08.05.02.003 | 0.001598% | | |
Rash | 23.03.13.001 | 0.000799% | | Not Available |
Sepsis | 11.01.11.003 | 0.000208% | | |
Skin disorder | 23.03.03.007 | 0.000533% | | Not Available |
Skin exfoliation | 23.03.07.003 | 0.000533% | | Not Available |
Stevens-Johnson syndrome | 11.07.01.005; 10.01.03.020; 23.03.01.007; 12.03.01.014 | 0.001332% | | |
Stomatitis | 07.05.06.005 | 0.004263% | | |
Tachycardia | 02.03.02.007 | - | - | Not Available |
Thrombocytopenia | 01.08.01.002 | 0.000533% | | Not Available |
Toxic epidermal necrolysis | 23.03.01.008; 12.03.01.015; 11.07.01.006; 10.01.01.006 | - | - | |
Tumour lysis syndrome | 14.05.01.004; 16.32.03.002 | 0.000139% | | |
Upper respiratory tract infection | 22.07.03.011; 11.01.13.009 | - | - | |
Vomiting | 07.01.07.003 | - | - | |
White blood cell count decreased | 13.01.06.012 | 0.000533% | | |
Malignant neoplasm progression | 16.16.01.005 | 0.001112% | | Not Available |
Adverse event | 08.06.01.010 | - | - | Not Available |
Decreased appetite | 14.03.01.005; 08.01.09.028 | - | - | |